BIOMAT Database Logo BIOMAT Database Logo

Prion protein (PrPc) promotes beta-amyloid plaque formation. 2005

Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Institute of Neuropathology, University Hospital, Münster, Germany.

Prion protein (PrP) has been localized to amyloid-beta (Abeta) senile plaques in aging and Alzheimer disease, but it is unknown whether PrP is directly involved in plaque formation or represents a reaction to amyloid deposition. To evaluate possible functional effects of PrP in Abeta plaque formation, we analyzed bigenic mice (TgCRND8/Tg7), carrying mutant human amyloid precursor protein (APP) 695 (APP(Swed+Ind), TgCRND8) as well as the wild-type Syrian hamster prion protein gene (sHaPrP, Tg7), showing Abeta plaques at 3 months of age as well as highly increased HaPrP(c) levels. Compared to the control group, consisting of animals carrying only mutant APP, bigenic mice showed a higher number of senile plaques in the cerebral cortex, while APP transcription and Abeta40/Abeta42 levels were unchanged. Double-labelling immunofluorescence showed co-localization of Abeta and PrP in virtually all plaques in the brains of both control and experimental animals. Our data suggest that PrP promotes plaque formation, and that this hitherto unknown functional role of PrP appears to be mediated by increased Abeta aggregation rather than by altered APP transcription or processing.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
[Functions of prion protein PrPc].
January 2007, Medecine sciences : M/S,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Different chromogranin immunoreactivity between prion and a-beta amyloid plaque.
April 2003, Neuroreport,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Amyloid-beta and PrPC: it takes two.
May 2009, Nature reviews. Neuroscience,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrPC.
October 2018, Molecular neurobiology,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Beta-Secretase 1 Recruits Amyloid-Beta Precursor Protein to ROCK2 Kinase, Resulting in Erroneous Phosphorylation and Beta-Amyloid Plaque Formation.
June 2023, International journal of molecular sciences,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Regulation of focal adhesion formation and filopodia extension by the cellular prion protein (PrPC).
January 2009, FEBS letters,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice.
May 2010, Journal of immunology (Baltimore, Md. : 1950),
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695.
August 1996, Acta neuropathologica,
Katja Schwarze-Eicker, and Kathy Keyvani, and Nicole Görtz, and David Westaway, and Norbert Sachser, and Werner Paulus
Underglycosylated prion protein modulates plaque formation in the brain.
March 2020, The Journal of clinical investigation,
Copied contents to your clipboard!